| Literature DB >> 35412064 |
Kim Vanessa Steinke1,2, Hartmut Möbius3,4, Hans-Jürgen Christen5, Hans-Jürgen Welkoborsky3,4.
Abstract
Vagus nerve stimulation (VNS) is a therapeutic procedure that can be applied in a palliative setting in patients with treatment-refractory epilepsy who are not suitable for epilepsy surgery. The mechanism of action of VNS is currently not completely understood but appears to depend on a modification of neurotransmitter metabolism. Data of 25 patients with treatment-refractory epilepsy who underwent implantation of a vagus nerve stimulator were retrospectively analyzed in a monocentric study. A reduction in epileptic seizure rate of 28% was observed 3 months after initial activation and of 32.9% after 6-12 months. The responder rate (reduction in seizure rate of more than 50% compared to before implantation) was 40% 6-12 months after initial activation. In one third of patients, a reduction in epileptic seizure rate of at least 75% occurred. Adverse effects of surgery or the stimulation were rare.Entities:
Keywords: Antiepileptic drugs; Drug-resistant epilepsy; Electric stimulation; Implantable neurostimulators; Pediatrics
Mesh:
Year: 2022 PMID: 35412064 DOI: 10.1007/s00106-022-01164-y
Source DB: PubMed Journal: HNO ISSN: 0017-6192 Impact factor: 1.284